Lactic acid bacteria strain and its use for the protection of food products

ABSTRACT

The present invention refers to a strain of  Lactobacillus curvatus  bacteria deposited in the Deutsche Sammlung von Mikroorganismen und Zellkulturen GmBH (DSMZ) under thew accession number DSM 18775, as well as to compositions, cultures and food products comprising thereof. The strain of the invention is useful for preserving food products, especially under refrigerated conditions.

The present invention relates to a new lactic acid bacterium thatproduces protease-sensitive antimicrobial agents (bacteriocins) at lowstorage temperatures. Particularly, the present invention refers toLactobacillus curvatus DSM 18775, which has been found to be useful forbioprotection of refrigerated products such as Ready-To-Eat (RTE) meatand dairy products.

BACKGROUND ART

Bacterial contamination of food products is known to be responsible forspoilage and for the transmission of food borne illness. This problem isparticularly important in RTE meats and dairy products which are notnormally reheated by consumers prior to ingestion and which are storedfor extended times in refrigerators at 2-10° C. An exemplary case isListeria monocytogenes which is a pathogenic bacterium of particularconcern in food products, such as vacuum- or modified atmosphere(MA)-packed RTE meat products, due to its tolerance to refrigerationtemperatures, relatively high concentrations of NaCl and anaerobicconditions or in products, such as Fresh Cheese, due to the lack of aheat inactivation step. As a result, a great deal of effort has beenexpended in attempts to identify natural products that can be safelyadded to foods for the purpose of inhibiting bacterial growth.

It is well-known to use lactic acid bacteria as starter cultures toinduce fermentation of meat products, typically raw salted meatproducts. The term “starter culture” refers to a preparation containingmicrobial cells that is intended for inoculating a food matrix to besubjected to fermentation. Starter cultures for meat fermentation arecommonly comprised by one or more lactic acid bacteria. The starterculture is intended for providing the desired change in thecharacteristics of the food matrix during fermentation (e.g. a desiredacidification, and certain other sensory and technological parameters).Typically, a starter culture will proliferate during the fermentationprocess. During the fermentation process the lactic acid bacteriaprimarily produce lactic acid whereby pH drops to the desired pH-valuedepending on the culture and the processing conditions (temperature,sugar type/content etc.), and importantly, the sensory properties of theproduct are distinctly changed.

Antagonistic cultures added to food to inhibit pathogens and/or extendshelf life without changing the sensory properties of the product aretermed “protective cultures”. In contrast to starter cultures,protective cultures are not intended to change the sensory properties ofthe product. Their use or that of their metabolic products (organicacids, hydrogen peroxide, enzymes and bacteriocins) is often referred toas “biopreservation” or “bioprotection” (Castellano, P. and Vignolo, G.,“Inhibition of Listeria innocua and Brochothrix thermrnosphacta invacuum-packaged meat by addition of bacteriocinogenic Lactobacilluscurvatus CRL705 and its bacteriocins”, 2006, Letters in AppliedMicrobiology. Vol. 43: 194-199). This study demonstrates abacteriostatic effect on a non-patogenic Listeria species. Nobacteriocidal effect to Listeria is reported. Furthermore the “sensoric”evaluation performed was limited to pH measurements.

Besides the establishment of biopreservation as a method to ensuremicrobiological safety without changing the sensoric characteristics ofthe product, bioprotective cultures have also been evaluated for theirpotential of preventing growth of spoilage bacteria (Vermieren, L. etal., “Evaluation of meat born lactic acid bacteria as protectivecultures for the biopreservation of cooked meat products”, 2004,International Journal of Food Micro-biology, 96: 149-164).

The sensory acceptability of cooked meat products treated withbioprotective cultures may limit the use of the preservation method, andthe buffering capacity as well as the content of glucose have shown tobe key elements to avoid sensory deviations when applying bioprotectivecultures (Vermieren et al., supra).

A re-growth of Listeria monocytogenes has often been observed with theuse of bioprotective cultures after an initial phase of inhibition.Re-growth has been ascribed to the development of resistance of L.monocytogenes to the bacteriocins, degradation of bacteriocin moleculeswith endogenous proteases produced during the growth phase, adsorptionof the bacteriocins to the surface of the producer strain, or specificinteractions with the food matrix (Dicks. L. M. T. et al., “Use ofbacteriocin-producing starter cultures of Lactobacillus plantarum andLactobacillus curvatus in production of ostrich meat salami”, 2004, MeatScience, 66: 703-708).

The European patent application EP 1.475.432 discloses two Lactobacilluscurvatus strains, deposited as PTA-5150 and PTA-5159 and their use forreducing the growth of a microbe in a food or pharmaceuticalcomposition.

The U.S. Pat. No. 4,886,673 discloses three bacteria strainsLactobacillus curvatus DSM 4265, Microccocus varians DSM4263, andDebaromyces hansenii DSM 4260 and their use for preserving meatproducts. Example 1 describes the use of Lactobacillus curvatus DSM 4265in the production of cut raw sausage.

The European patent application EP 0.640.291 discloses the use ofLactobacillus curvatus DSM8430 as a starter culture in salamiproduction. It is specifically mentioned that optimal bacteriocinproduction occurs at temperatures between 15 and 20° C. and that theactivity decreases at low temperatures (+4° C.).

Vogel, R. F. et al., (1993, System. Appl. Microbiol., 16: 457-462)discloses the use of Lac-tobacillus curvatus strain LTH 1174 as astarter culture in salami production. It is specifically mentioned thatoptimal bacteriocin production occurs at temperatures between 15 and 20°C. and that the activity decreases at low temperatures (+4° C.).

Benkerroum, N. et al. (2005, J. Appl. Microbiol., 98: 56-63) disclosesthe use of Lactobacillus curvatus strain LBPE as a starter culture inthe production of dry-fermented sausages. The fermentation is performedat 30° C. and the drying at 14-16° C. No bioprotective effect wasdemonstrated at low temperatures.

Mauriello, G. et al. (2004, J. Appl. Microbiol., 97: 314-322) disclosesthe use of polyethylene films for food packing that are treated withpartially purified bacteriocin of Lactobacillus curvatus strain 32Y. Inorder to produce the bacteriocin this particular strain is grown at 30°C.

SUMMARY OF THE INVENTION

The problem to be solved by the present invention is the provision of abacteria strain which inhibits the growth of food-borne pathogenic andspoilage bacteria at low temperatures (2-10° C.) without changing thesensory properties of the food product.

The solution is based on a Lactobacillus curvatus strain deposited withthe accession number DSM 18775.

As it is illustrated below in a non-restricted way, it has been foundthat the Lactobacillus curvatus strain of the present invention isuseful for the bioprotection of food products. The strain of theinvention can be useful and has proven particularly useful for theinhibition of food-borne pathogenic bacteria and spoilage bacteria owingto the production of bacteriocins.

Food-borne pathogenic and spoilage bacteria can be aerobic, anaerobic orfacultative anaerobic, and thus, the elimination of oxygen alone from afood package or from a food storage environment will not effectivelyeliminate all types of undesired bacteria. More-over, control of thetemperature in the storage of food is not totally effective to precludethe growth of such bacteria because several types of pathogenic andspoilage bacteria are able to grow at various temperatures. On the otherhand, there are pathogenic bacteria, which due to their tolerance torefrigeration temperatures, relatively high concentrations of NaCl andanaerobic conditions, are of particular concern in RTE food products.

The inventors of the present invention have observed that underrefrigeration conditions, the Lactobacillus curvatus strain of theinvention produces bacteriocins, providing considerable reductions innumbers of food-borne pathogenic bacteria without causing undesirablesensory changes, and also preventing growth of spoilage bacteria in thefood product. The fact that the Lactobacillus curvatus of the inventionis able to produce bacteriocins at a refrigeration temperature impliesthat said strain can be used for the bioprotection of refrigeratedproducts, and particularly of ready to eat refrigerated productspackaged in vacuum or modified atmosphere.

Thus, in one aspect the present invention relates to a strain ofLactobacillus curvatus bacterium deposited in the Deutsche Sammlung vonMikroorganismen und Zellkulturen GmBH (DSMZ) under the accession numberDSM 18775.

A culture sample of the microorganism was deposited on Sep. 11, 2006 inthe Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ)under the accession number DSM 18775.

In a second aspect the present invention relates to a culture obtainedfrom the strain according to the first aspect of the invention.

An important aspect in the evaluation of the use of a strain as abioprotective culture is the ability of the strain to work in the foodproduct for which it is intended. In this respect it is not onlyimportant that the strain is able to inhibit any undesired food-bornepathogenic bacteria in the product under relevant storage conditions butalso that it does not produce any undesired sensory effects (off-taste,off-odors or unwanted color changes). The Lactobacillus curvatus strainof the present invention inhibits the food-borne pathogenic bacteriaconsiderably when applied on a wide range of real RTE meat productsthroughout storage at relevant storage conditions. The inventors haveproven by sensory analyses that the culture of the invention does notnegatively affect the sensory quality of the food products (such asvarious RTE meat products) under relevant storage conditions, as it isillustrated below.

Furthermore, in contrast to other strains used as bioprotectivecultures, when the culture of the invention is used as a bioprotectiveculture, no re-growth of L. monocytogenes is observed.

Hence, when using a culture according to the present invention there arereduced health risks associated with the ingestion of refrigeratedproducts, due to increased safety of the product during the shelf life.Consequently, the economic loss to the food industry can be considerablyreduced.

In a third aspect the present invention relates to a process forpreparing a composition inhibiting the growth of at least one food-bornepathogenic bacterium said process comprising: (a) culturing cells of astrain of Lactobacillus curvatus according to the first aspect of theinvention, which upon culturing in a culture medium, produces abacteriocin which has inhibitory activity against bacterial strainsincluding Listeria monocytogenes to obtain a supernatant comprising thebacteriocin; and (b) separating the supernatant from the cultured cellsto obtain the supernatant, thus obtaining a supernatant compositioncomprising the bacteriocin.

In one embodiment of this aspect the bacteriocin comprising supernatantcomposition is further subjected to a drying step to obtain a driedculture eluate product. The drying step may conveniently be freezedrying or spray drying. As described in example 8 the process results ina dried culture eluate product which inhibits Listeria monocytogenes onmeat products packed in a modified atmosphere or in vacuum.

In a further embodiment the growth inhibiting composition have abacteriocidal effect on at least one food-borne pathogenic bacteriumwhen sufficient amounts are provided. A preferred embodiment is a growthinhibiting composition having a bacteriocidal effect on Listeriamonocytogenes when provided in sufficient amounts. This is illustratedin example 8 FIG. 7 a.

In a fourth aspect the present invention relates to the culture eluatecomposition resulting from the above-mentioned processes.

In a fifth aspect the present invention relates to the culture mediumcomposition resulting from step (a) of the process of the third aspectof the invention.

In a sixth aspect the present invention relates to the supernatantcomposition comprising the bacteriocin resulting from step (b) of theprocess of the third aspect of the invention.

In a seventh aspect the present invention relates to a bacteriocin whichhas inhibitory activity against bacterial strains including Listeriamonocytogenes obtainable by the process according to the third aspect ofthe invention, as well as to cell-free Lactobacillus curvatus strainculture-medium-supernatant composition and bactericides comprising saidbacteriocin.

In an eighth aspect, the present invention relates to compositions forpreserving food products which comprise the Lactobacillus curvatusstrain according to the first aspect of the invention or the supernatantcomposition according to the filth aspect of the invention.

In a ninth aspect, the present invention relates to a food productcomprising the Lactobacillus curvatus strain according to the firstaspect of the invention.

In a tenth aspect, the present invention relates to the use of strainsand cultures of Lactobacillus curvatus according to the first aspect ofthe invention or the supernatant composition according to the fifthaspect of the invention for preserving food products.

In an eleventh aspect, the present invention relates to the use ofstrains and cultures of Lactobacillus curvatus strain according to thefirst aspect of the invention or the supernatant composition accordingto the fifth aspect of the invention, for inhibiting the growth offood-borne pathogenic bacteria on food products preserved in arefrigerated state.

In a twelfth aspect, the present invention relates to the use of strainsand cultures of Lactobacillus curvatus strain according to the firstaspect of the invention or the supernatant composition according to thefifth aspect of the invention, for preventing the growth of spoilagebacteria in food products preserved in a refrigerated state.

In a thirteenth aspect, the present invention relates to a method ofpreserving food products characterized in that Lactobacillus curvatus,according to the first aspect of the invention, is added in an effectiveamount to said products.

In a fourteenth aspect, the present invention relates to a method forcontrolling Listeria contamination in a food product, on food processingequipment, or on food storage containers, comprising applying theLactobacillus strain with the accession number DSM 18775 to a foodproduct or food processing equipment in an amount sufficient to reducethe amount or prevent growth of Listeria.

Throughout the description and claims the word “comprise” and variationsof the word, such as “comprising”, is not intended to exclude othertechnical features, additives, components, or steps. Additional objects,advantages and features of the invention will become apparent to thoseskilled in the art upon examination of the description or may be learnedby practice of the invention. The following examples and drawings areprovided by way of illustration, and are not intended to be limiting tothe present invention.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 represents the cell counts of L. monocytogenes in slices ofMortadella sausages inoculated with (▪) or not inoculated with (♦) DSM18775 (initial level of 10⁷ CFU/g). The slices of Mortadella sausageswere packed in modified atmosphere (30% CO₂ and 70% N₂) and stored at 7°C. Cell counts were based on determinations made on two different slicesof meat, and the bars indicate the standard deviations between theseduplicate determinations.

FIG. 2 represents the cell counts of L. monocytogenes in slices ofMortadella sausages made of finely chopped meat inoculated with (▪) ornot inoculated with (♦) DSM 18775 (initial level of 10⁷ CFU/g). Theslices of Mortadella sausages were packed in modified atmosphere (30%CO₂ and 70% N₂) and stored at 7° C. Cell counts were based ondeterminations made on two different slices of meat, and the barsindicate the standard deviations between these duplicate determinations.

FIG. 3 represents the cell counts of L. monocytogenes in slices ofcooked, smoked ham, inoculated with (▪) or not inoculated with (♦) DSM18775 (initial level of 10⁷ CFU/g). The ham slices were packed inmodified atmosphere (30% CO₂ and 70% N₂) and stored at 7° C. Cell countswere based on determinations made on two different slices of meat, andthe bars indicate the standard deviations between these duplicatedeterminations.

FIG. 4 represents the cell counts of L. monocytogenes in Wiener Sausage,inoculated with (▪) or not inoculated with (♦) DSM 18775 (initial levelof 10⁷ CFU/g). The Wiener Sausages were vacuum-packed and stored at 7°C. Cell counts were based on determinations made on two differentsausages, and the bars indicate the standard deviations between theseduplicate determinations.

FIG. 5 represents the cell counts of L. monocytogenes in slices ofcooked ham, inoculated with (▪) or not inoculated with (♦) DSM 18775(initial level of 10⁷ CFU/g). The ham slices were packed in modifiedatmosphere (30% CO₂ and 70% N₂) and stored at 5° C. Cell counts werebased on determinations made on two different slices of cooked ham, andthe bars indicate the standard deviations between these duplicatedeterminations.

FIG. 6 represents the development in pH in cheeses inoculated with DSM18775 (▪) or not inoculated with DSM 18775 (♦) (initial level of 10⁷CFU/g). The cheeses were packed in vacuum and stored at 9° C. pH ismeasured in a suspension of cheese and water (1:1) stirred for 30 minbefore measurement of pH (using a PHM 92 pH-meter, Radiometer,Copenhagen, DK).

FIG. 7. Cell counts of L. monocytogenes exposed to culture eluate ofDSM18775 or MicroGARD 730 in different concentrations, as explained inthe figure legends to the right, on slices of emulsion sausage storedunder Modified Atmosphere (MA, 30% CO₂ and 70% N₂) 7a, or vacuum (7b) at7° C. Cell counts were based on determinations made on two differentslices of meat, and the bars indicate the standard deviations betweenthese duplicate determinations.

DETAILED DESCRIPTION OF PARTICULAR EMBODIMENTS

The Lactobacillus curvatus strain DMS 18775 of the present invention isa lactic acid bacterium. It was isolated from fermented food and wasidentified as Lactobacillus curvatus by protein gel electrophoresisfollowed by analyzing and clustering with the reference profiles of theLMG culture collection database. Furthermore, by using an API profilecharacterization, DMS 18775 was identified as Lactobacillus curvatuswith 63.4% probability. The strain was characterized by fullmetabolization of: D-Ribose. D-Galactose, D-Glucose, D-Fructose,D-Mannose, N-Acetylglucosamine, Esculine, D-Maltose and D-Trehalose andpartial metabolization of D-Saccharose after 48 h incubation at 30° C.The strain was deposited on Nov. 9, 2006 under the terms of the Budapesttreaty at ‘Deutsche Sammlung von Microorganismen und Zellkulturen’ GmbH(DSMZ). It was assigned de-posit number DSM 18775. The anti-listerialbacteriocin produced by DSM 18775 was determined in an agar welldiffusion assay using Lactobacillus sakei NCFB 2714 as the indicatororganism.

The scope of the present invention also encompasses a strain ofLactobacillus curvatus obtained by mutation, variation or recombinationof the strain of Lactobacillus curvatus DMS 18775, provided that theresulting strain has the ability at a temperature ranging from to 2 to10° C. of inhibiting the growth of food-borne pathogenic bacteriawithout causing sensory changes in food.

In the process for preparing the bacteriocin according to the presentinvention, the strain of the present invention which produces thebacteriocin, is cultured in a medium and under conditions which arefavorable for growth, the supernatant is isolated from the resultingculture by separating the supernatant from the cultured cells to obtaina supernatant containing the bacteriocin, and to effect separation, theresulting culture is centrifuged and a supernatant extract containingthe bacteriocin is obtained. The supernatant may be concentrated toobtain a concentrate comprising the bacteriocin, and an isolated andpurified bacteriocin may be obtained from the supernatant andconcentrate and may be dehydrated.

In a particular preferred embodiment of this process the supernatantcomposition is further subjected to a drying step to obtain a driedculture eluate product. The drying step may conveniently be freezedrying or spray drying, but any drying process which is suitable fordrying of bacteriocins, also including vacuum drying and air drying, arecontemplated. Although the bacteriocin produced at low temperatures byLactobacillus curvatus DSM 18775 not yet is characterized in details itis known that certain Lactobacillus curvatus may produce class II abacteriocins including Sakacin. Class II a bacteriocins are smallheat-stable proteins therefore we expect that even drying methods, whichresult in moderate heating of the culture eluate product, will result inactive compositions.

The bacteriocin according to the present invention is characterized inmore detail below with the aid of various microbiological, biochemicaland genetic findings which illustrate its properties. The percentagesare given by weight. Unit of antibacterial activity is according to the“agar well test”. Within the context of the present exposition,inhibitory activity is defined in terms of arbitrary units.

The agar well test is used to determine whether the culture supernatantcontaining the bacteriocin according to the present invention exhibitsinhibitory activity against different strains of spores and bacteria.The inhibition spectrum of the supernatant is thus determined.

The term “food product” as used herein refers to any food that issusceptible to spoilage as a result of bacterial growth andproliferation. Such food products include, but are not limited to, meat,dairy products, vegetables, fruits and grains.

The terms “refrigerated product” or “preserved in a refrigerated state”are equally used and refer to food products which are stored attemperatures ranging from to 2 to 10° C. The food product can be eitherpackaged under vacuum or at modified atmosphere.

As used herein, the term “meat” refers to any meat product or meatby-product (including those processed) from an animal which is consumedby humans or animals, including, without limitation, meat from bovine,ovine, porcine, poultry, fish and crustaceous seafood. As used in thepresent application, the term “ready to eat meat product”, also referredto as RTE meat product, is intended to include any meat product whichdoes not require cooking prior to consumption.

The term “dairy product” is intended to include any food product madeusing milk or milk products, including, but not limited to, milk,yogurt, ice cream, cheese, butter, and cream.

As used herein the term “shelf life” means the period of time that afood product remains saleable to retail customers. In traditional meatprocessing, the shelf life of meat and meat by-products is about 30 to40 days after an animal has been slaughtered. Refrigeration of meatduring this period of time is expected to largely arrest and/or retardthe growth of pathogenic bacteria, and to a lesser extent, spoilagebacteria. After about 30 to 40 days, however, refrigeration is no longerable to effectively control the proliferation of spoilage bacteria belowacceptable levels.

The term “bacteriocidal effect” as used herein refers to any type oftreatment which effect the killing of bacteria (i.e. which reduce theirnumbers). This is in contrast to a “bacteriostatic effect” which refersto the situation where the treatment only inhibits the growth orreproduction of the bacteria. An agent is said to be a bactericide or abacteriocide if the agent is able to kill one or more type of bacteria.A bacteriocide is said to possess bacteriocidal or bactericidalactivity.

By “bacteriocins” we refer to peptides or protein molecules releasedextracellularly that are able to kill certain other closely relatedbacteria by a mechanism by which the producer cell exhibits a degree ofspecific immunity.

The term “spoilage bacteria” as used herein refers to any type ofbacteria that act to spoil food. Spoilage bacteria may grow andproliferate to such a degree that a food product is made unsuitable orundesirable for human or animal consumption. Bacteria are able toproliferate on food surfaces, such as meat surfaces, by assimilatingsugars and proteins on such surfaces. By metabolizing these components,spoilage bacteria create by-products including carbon dioxide, methane,nitrogenous compounds, butyric acid, propionic acid, lactic acid, formicacid, sulfur compounds, and other undesired gases and acids. Theproduction of such by-products alter the color of meat surfaces, oftenturning meat from a red color to a brown, grey or green color. Gaseousby-products generated by spoilage bacteria also give spoiled meat anundesirable odor. The color and odor alterations of meat due to thegrowth of spoilage bacteria on a the surface of a meat product oftenmake such food product unsaleable to consumers.

In addition to the control of spoilage bacteria, another significantconcern in the food processing industry is controlling the growth offood-borne pathogenic bacteria. As used herein, the term “food-bornepathogenic bacteria” refers to any food poisoning organism that iscapable of causing disease or illness in animals or humans. The term“food-borne pathogenic bacteria” will be understood to include bacteriathat infect the food product (for instance meat) and thereby causedisease or illness, as well as bacteria that produce toxins that causedisease or illness. Preferably, the food-borne pathogenic bacteria isselected from the group: Aeromonas caviae; Aeromonas hydrophila;Aeromonas sobria; Bacillus cereus; Campylobacter jejuni; Citrobacterssp.; Clostridium botulinum; Clostridium perfringens; Enterobacter ssp.;Enterococcus ssp.; Escherichia coli enteroinvasive strains; Escherichiacoli enteropathogenic strains; Escherichia coli enterotoxigenic strains;Escherichia coli O157:H7; Klebsiella ssp.; Listeria monocytogenes;Plesiomonas shigelloides; Salmonella ssp.; Shigella ssp.: Staphylococcusaureus; Streptococcus ssp.; Vibrio cholerae; Yersinia enterocolitica.More preferably, the pathogenic-bacteria are Listeria monocytogenes.

As used herein, the expression “effective amount” refers to the amountof Lactobacillus curvatus according to the first aspect of the inventionwhich gives rise to an inhibition of the bacterial growth or a reductionof the number of other bacteria from the food product.

The Invention Presented in the Form of Claims

Preferred aspects and embodiments of the invention may ne presented inthe form of so-called claims. This is given below.

1. A strain of Lactobacillus curvatus bacterium deposited in theDeutsche Sammlung von Mikroorganismen und Zellkulturen GmBH (DSMZ) underthe accession number DSM 18775.2. A strain of Lactobacillus curvatus according to claim 1 or obtainedby mutation, variation or recombination of the strain according to claim1, characterized in that it has the ability at a temperature rangingfrom 2 to 10° C. of inhibiting the growth of food-borne pathogenicbacteria without causing sensory changes in food.3. A culture obtained from the strain according to any of the claims 1and 2.4. A composition characterized in that it comprises the Lactobacilluscurvatus strain according to any of the claims 1 and 2.5. A composition for preserving food products characterized in that itcomprises the Lactobacillus curvatus strain according to any of theclaims 1 and 2.6. A composition for preserving food products characterized in that itcomprises the Lactobacillus curvatus strain according to claim 1.7. The composition according to any of the claims 5 to 6, for delayingthe development of food-borne pathogenic bacteria.8. The composition according to any of the claims 5 to 7, for delayingthe development of spoilage bacteria.9. The composition according to any of the claims 5 to 8, wherein thefood product is packaged under vacuum or at modified atmosphere.10. The composition according to any of the claims 5 to 9, wherein thefood product is RTE meat.11. The composition according to any of the claims 5 to 10, wherein thefood product is a dairy product.12. A process for preparing a composition having inhibitory activitycomprising:

-   -   (a) culturing cells of a strain of Lactobacillus curvatus as        claimed in any of the claims 1 to 2, which upon culturing in a        culture medium, produces a bacteriocin which has inhibitory        activity against bacterial strains including Listeria        monocytogenes to obtain a supernatant comprising the        bacteriocin; and    -   (b) separating the supernatant from the cultured cells to obtain        the supernatant, thus obtaining a supernatant composition        comprising the bacteriocin.        13. The process according to claim 12 further comprising        isolating the bacteriocin from the supernatant composition to        obtain a purified bacteriocin product.        14. The process according to claim 12 further comprising        concentrating the supernatant composition to obtain a        concentrate comprising the bacteriocin.        15. The culture medium composition resulting from step (a) of        the process of claim 12.        16. The supernatant composition comprising the bacteriocin        resulting from step (b) of the process of claim 12.        17. A bacteriocin which has inhibitory activity against        bacterial strains including Listeria monocytogenes obtainable by        the process of claims 12 to 14.        18. A cell-free Lactobacillus curvatus strain        culture-medium-supernatant composition comprising the        bacteriocin of claim 17.        19. A bactericide which comprises the bacteriocin as defined in        claim 17.        20. A food product comprising the Lactobacillus curvatus or a        variant or mutant thereof according to any of the claims 1 and        2.        21. A food product comprising the Lactobacillus curvatus        according to claim 1.        22. The food product according to any of the claims 20 to 21,        wherein the food product is packaged under vacuum or at modified        atmosphere.        23. The food product according to any of the claims 20 to 22        which is preserved in a refrigerated state and has on its        surface a biological barrier consisting of Lactobacillus        curvatus according to any of the claims 1 and 2.        24. Use of strains and cultures of Lactobacillus curvatus        according to any of the claims 1 to 3 or the supernatant        composition according to claim 16, for preserving food products.        25. Use of strains and cultures of Lactobacillus curvatus        according to any of the claims 1 and 3, for preserving food        products.        26. Use of strains and cultures of Lactobacillus curvatus        according to any of the claims 1 to 3 or the supernatant        composition according to claim 16, for inhibiting the growth of        food-borne pathogenic bacteria on food products preserved in the        refrigerated state.        27. Use of strains and cultures of Lactobacillus curvatus        according to any of the claims 1 to 3 or the supernatant        composition according to claim 16, for delaying the appearance        of unwanted sensory effects (off-taste, off-odors or unwanted        color changes) in food products preserved in the refrigerated        state.        28. Use of strains and cultures of Lactobacillus curvatus        according to any of the claims 1 to 3 or the supernatant        composition according to claim 16, for preventing the growth of        spoilage bacteria in food products preserved in the refrigerated        state.        29. The use according to any of the claims 24 to 28, wherein the        food product is packaged under vacuum or at modified atmosphere.        30. The use according to any of the claims 24 to 29, wherein the        food product is a RTE meat product.        31. The use according to any of the claims 24 to 29, wherein the        food product is a dairy product.        32. The use according to any of the claims 24 to 31, wherein the        food-borne pathogenic bacterium is Listeria monocytogenes.        33. A process of preserving food products characterized in that        Lactobacillus curvatus according to any of the claims 1 to 2 or        the supernatant composition according to claim 16 is added in an        effective amount to said food products.        34. The process according to claim 33, wherein the Lactobacillus        curvatus strain or the supernatant composition is added during        the manufacture process of the food product.        35. The process according to claim 33, wherein the Lactobacillus        curvatus strain or the supernatant composition is added to the        food product so as to form a barrier on the surface of said        product.        36. The process according to any of the claims 33 to 35, wherein        the food product is a RTE meat.        37. The process according to any of the claims 33 to 35, wherein        the food product is a dairy product.        38. A method for controlling Listeria contamination in a food        product, on food processing equipment, or on food storage        containers, comprising applying the Lactobacillus strain with        the accession number DSM 18775 to a food product or food        processing equipment in an amount sufficient to reduce the        amount of Listeria.

EXAMPLES Example 1 Strain Identification and Bacteriocin Production

After growth of DSM 18775 in MRS (De Man, Rogosa and Sharpe, Difco, V WR, Herlev, Denmark) broth for 22 h at 25° C., the cell suspension wascentrifuged at 4,000×g for 15 min. The supernatant was adjusted to pH6.0±0.1 with 1N NaOH and filter sterilized (0.45 μm). Two-fold dilutionsof the supernatant were made in sterile ion-exchanged water and 50 μl ofeach bacteriocin dilution were added to wells in MRS agar containing theindicator organism, Lactobacillus sakei NCFB 2714, in a concentration of10⁶ CFU/ml. To verify the proteinaceus nature of the inhibitorysubstances, a solution of the proteolytic enzyme, Proteinase K, wasapplied next to one well of the agar well diffusion assay. Thebacteriocin activity of the cell supernatant was defined as thereciprocal of the highest dilution causing an inhibition zone in theagar assay. Inhibition zones caused by a proteinaceus compound,bacteriocin, were observed with an activity of 500 units/ml cellsupernatant, clearly indicating the ability of DSM 18775 to produceconsiderable amounts of anti-listerial bacteriocin.

Example 2 Application Trial with Lactobacillus curvatus DSM 18775 onSliced Mortadella-Type Sausage (I)

The anti-listerial effect of DSM 18775 and the sensory Impact of theculture were evaluated on sliced Mortadella sausage. A 5 strain L.monocytogenes cocktail was added to the surface of the RTE meat product(10³ CFU/g) followed by inoculation of the bioprotective culture (10⁷CFU/g). The product was packed in a modified atmosphere (30% CO₂ and 70%N₂) and stored at 7° C. for 27 days.

Cell counts of the bioprotective culture were determined by platingappropriate 10-fold dilutions made in peptone saline onto MRS-agarplates and incubating anaerobically for 3 days at 30° C. DSM 18775proliferated on the product and reached approx. 10⁸ CFU/g after 1 weekof storage and approx. 10⁹ CFU/g by the end of storage.

Listeria cell counts were determined by plating appropriate 10-folddilutions made in peptone saline onto listeria selective PALCAM agarplates (Oxoid A/S, Glostrup, Denmark) and incubating microaerophilic for48 h at 37° C. These cell counts can be seen in FIG. 1, showing abacterlocidal effect of DSM 18775 on L. monocytogenes.

Sensory descriptive triangle tests carried out by a panel of 10 judgesdid not show any significant effect of adding the bioprotective cultureupon 11 days of storage. After 21 days of storage (end of shelf life),the products with added bioprotective culture were perceived as fresherin taste and odor compared to the products without DSM 18775 added,which were characterized as more insipid.

Example 3 Application Trial with Lactobacillus curvatus DSM 18775 onSliced Mortadella-Type Sausage (II), Very Finely Chopped

The anti-listerial effect of DSM 18775 and the sensory impact of theculture was evaluated on sliced Mortadella sausage made of very finelychopped meat. A 5 strain L. monocytogenes cocktail was added to thesurface of the RTE meat product (10³ CFU/g) followed by inoculation ofthe bioprotective culture (10⁷ CFU/g). The product was packed in amodified atmosphere (30% CO₂ and 70% N₂) and stored at 7° C. for 27days.

Cell counts of the bioprotective culture were determined by platingappropriate 10-fold dilutions made in peptone saline onto MRS-agarplates and incubating anaerobically for 3 days at 30° C. DSM 18775proliferated on the product and reached approx. 10⁸ CFU/g after 1 weekof storage and approx. 10⁹ CFU/g by the end of storage.

Listeria cell counts were determined by plating appropriate 10-folddilutions made in peptone saline onto listeria selective PALCAM agarplates (Oxoid A/S, Greve, Denmark) followed by microaerophilicincubation for 48 h at 37° C. Listeria cell counts can be seen in FIG.2, clearly illustrating a bacteriocidal effect of DSM 18775 on L.monocytogenes throughout 27 days of storage.

Sensory descriptive triangle tests carried out by a panel of 10 judgesdid not show any significant sensory effect of adding the bioprotectiveculture upon 11 days of storage or at the end of shelf life. i.e. after21 days of storage.

Example 4 Application Trial with Lactobacillus curvatus DSM 18775 onCooked, Smoked and Sliced Ham

The anti-listerial effect of DSM 18775 and the sensory impact of theculture was evaluated on cooked, smoked and sliced ham. A 5 strain L.monocytogenes cocktail was added to the surface of the RTE meat product(10³ CFU/g) followed by inoculation of the bioprotective culture (10⁷CFU/g). The product was packed in a modified atmosphere (30% CO₂ and 70%N₂) and stored at 7° C. for 27 days.

Cell counts of the bioprotective culture were determined by platingappropriate 10-fold dilutions made in peptone saline onto MRS-agarplates and incubating anaerobically for 3 days at 30° C. DSM 18775proliferated on the product and reached approx. 10⁸ CFU/g after 1 weekof storage and approx. 5×10⁸ CFU/g by the end of storage.

Listeria cell counts were determined by plating appropriate 10-folddilutions made in peptone saline onto listeria selective PALCAM agarplates followed by microaerophilic incubation for 48 h at 37° C. Thisproduct did not support growth of L. monocytogenes (probably due to thesmoking processing step), but larger reductions in cell counts of L.monocytogenes throughout 27 days of storage were observed in thepresence compared to the absence of DSM 18775 (FIG. 3).

Sensory descriptive triangle test carried out by a panel of 10 judgesdid not show any significant sensory effect of adding the bioprotectiveculture upon 11 days of storage or at the end of shelf life, i.e. after21 days of storage.

Example 5 Application Trial with Lactobacillus curvatus DSM 18775 onWiener Sausages

The anti-listerial effect of DSM 18775 and the sensory impact of theculture were evaluated on Wiener Sausages. A 5 strain L. monocytogenescocktail was added to the surface of the RTE meat product (10³ CFU/g)followed by Inoculation of the bioprotective culture (10⁷ CFU/g). Thesausages were vacuum packed and stored at 7° C. for 27 days.

Cell counts of the bioprotective culture were determined by platingappropriate 10-fold dilutions made in peptone saline onto MRS-agarplates and incubating anaerobically for 3 days at 30° C. DSM 18775proliferated on the product and reached approx. 10⁸ CFU/g after 1 weekof storage and approx. 5×10⁸ CFU/g by the end of storage.

Listeria cell counts were determined by plating appropriate 10-folddilutions made in peptone saline onto listeria selective PALCAM agarplates followed by microaerophilic incubation for 48 h at 37° C. Aninstant bacteriocidal effect of DSM 18775 was found on L. monocytogenesand the reduced cell count was constant throughout storage in contrastto the pronounced growth of L. monocytogenes found in the absence ofbioprotective culture in this RTE meat product (FIG. 4).

An agar well diffusion assay was used to detect bacteriocins produced byDSM 18775 in the Wiener Sausages using Lactobacillus sakei as indicatororganism. Bacteriocin was extracted from the sausages by homogenizingwith 0.02M HCl (1:2, w/v), centrifuging at 16,000×g for 5 min at 5° C.,adjusting the supernatant to pH 6.0±0.1 with 1N NaOH and filtersterilizing (0.45 μm). To verify the proteinaceus nature of theinhibitory substances, a solution of the proteolytic enzyme, ProteinaseK, was applied next to the sausage extract in the agar well diffusionassay. Inhibition zones caused by a proteinaceus compound, presumablybacteriocin, were observed from extracts derived from Wiener Sausageafter 11, 21 and 28 days of storage.

In sensory descriptive triangle tests carried out by a panel of 10judges Wiener Sausages with added DSM 18775 were evaluated as slightlydifferent, and fresher, than sausages without bioprotective cultureafter 11 days of storage, whereas no significant effect of DSM 18775 wasfound on the sensory quality after 21 days of storage. i.e. at the endof shelf life.

Example 6 Application Trial with Lactobacillus Curvatus DSM 18775 onCooked Sliced Ham

The anti-listerial effect of DSM 18775 and the sensory impact of theculture were evaluated on cooked sliced ham. A 5 strain L. monocytogenescocktail was added to the surface of the RTE meat product (10³ CFU/g)with or without the concomitant inoculation of the bioprotective culture(10⁷ CFU/g). The product was packed in a modified atmosphere (30% CO₂and 70% N₂) and stored at 5° C. for 4 weeks.

Cell counts of the bioprotective culture were determined by platingappropriate 10-fold dilutions made in peptone saline onto MRS-agarplates and incubating anaerobically for 3 days at 30° C. DSM 18775proliferated on the product and reached approx. 10⁸ CFU/g by the end ofstorage.

Listeria cell counts were determined by plating appropriate 10-folddilutions made in peptone saline onto listeria selective PALCAM agarplates followed by microaerophilic incubation for 48 h at 37° C. A clearbacteriocidal effect of DSM 18775 was found on L. monocytogenes as seenin FIG. 6 with 1-2 log₁₀ unit reductions observed throughout storage(FIG. 5).

In sensory descriptive triangle tests carried out by a panel of 8judges, no significant differences were found in the sensory quality ofthe products in the presence compared to the absence of bioprotectiveculture throughout the storage period.

Example 7 Application Trial with Lactobacillus curvatus DSM 18775 inFresh Cheese

20 kg whole milk (pasteurized at 72-73° C. homogenized and standardizedto 3.0% of butter fat) were added 3.5×10¹⁰ CFU of the bioprotectiveculture DSM 18775, corresponding to approx. 10⁷ CFU/g of cheese. At thetime of inoculation the temperature of the milk was 35° C. DSM 18775 waspre-ripened in the milk for 30 min at 35° C. before addition of therennet. The manufacture of the fresh cheese followed a standard protocolfor fresh cheese: cutting the curd, heating the curd at 43° C. for 30min, drainage of 50% whey, dry salting to obtain a final salt content of2% in the cheese. After manufacture, the cheese was divided into smallerpieces, vacuum packed separately and stored for 4 weeks at 9° C.

Cell counts of the bioprotective culture were determined by platingappropriate 10-fold dilutions made in peptone saline onto MRS-agarplates and incubating anaerobically for 3 days at 30° C. The initialcell count of DSM 18775 was 10-times lower than expected (approx. 10⁶CFU/g of cheese), but during storage, DSM 18775 proliferated in thecheese and reached approx. 10⁸ CFU/g after 4 weeks.

Throughout storage, a faster reduction of pH was observed in the cheesewith the added bioprotective culture, but by the end of storage nosignificant difference was observed in the cheese with or without thebioprotective culture as seen in FIG. 6.

A trained panel of three assessors evaluated the sensory impact ofadding the bioprotective culture to fresh cheese. The cheeses weremainly characterized on taste and texture. The assessment was done at10° C. The assessors described the cheese with the added DSM 18775 asfresher, more intense, with improved texture, compared to the cheesewithout the DSM 18775, which was characterized as neutral, tasteless andcrumbling.

Bacteriocins produced by DSM 18775 in the Fresh Cheese during storagewere determined in an agar well diffusion assay using Lactobacillussakei NCFB 2714 as the indicator organism. Bacteriocin was extractedfrom the cheese by homogenizing with 0.02M HCL (1:5, w/v), centrifugingat 16,000×g for 5 min at 5° C., adjusting the supernatant to pH 4.5±0.1with 1N NaOH and filter sterilizing (0.45 μm). To verify theproteinaceus nature of the inhibitory substances, a solution of theproteolytic enzyme, Proteinase K, was applied next to the cheese extractin the agar well diffusion assay.

Bacteriocin was produced and detected in the fresh cheese during storagein increasing amounts during the first 3 weeks (Table 1) and in aconcentration range expected to inhibit growth of L. monocytogenes inthe cheese.

TABLE 1 Bacteriocin activity in Bacteriocin activity in Day of analysischeese with added DSM cheese without added DSM during storage 18775(unit/mg) 18775 (unit/mg) 0 — — 7 8 — 14 16 — 21 32 — 28 32 —

Example 8 Comparison of Lactobacillus curvatus DSM 18775 Culture Eluatewith a Commercially Available Culture Eluate

The antilisterial effect of freeze dried eluate from DSM18775 wascompared to the effect of a similar type of product from Danisco,MicroGARD 730, on sliced emulsion sausages.

A 5-strain cocktail of Listeria monocytogenes in final concentrations ofapprox. 5e03 CFU/g was added to slices of emulsion sausages. Solutionsof culture eluates of DSM18775 and MicroGARD 730 dissolved in Milli-Qwater and filter sterilized (0.2 mm) were added in final concentrationsof 0.01 and 0.1% (w/w). As a control, the same volume of saline peptoneinstead of culture eluate was added to slices of emulsion sausage. Theinoculated slices of emulsion sausages were packed in ModifiedAtmosphere (MA 30% CO2+70% N2) or vacuum packed and stored at 7° C.

After 1 and 7 days of storage, the MA-packed and vacuum-packed meat wereexamined for the content of listeria by making appropriate 10-folddilutions in saline peptone and spread-plating on PALCAM agar platesfollowed by 2 days of microaerophilic incubation at 30° C. Sliceswithout added listeria were sensory evaluated after 1 and 7 days ofstorage.

The results of the cell counts are presented in FIG. 7 showing asuperior ability of DSM18775 eluate to inhibit growth of Listeriamonocytogenes under both packaging conditions. MicroGARD 730 only had aslight growth inhibitory effect at the highest concentration (0.1%) andunder MA-conditions. Culture eluate of DSM18775, on the contrary, wasable to prevent growth of Listeria monocytogenes at the highconcentration of 0.1% under MA-packaging and almost prevented growthunder vacuum.

Sensory evaluations showed no effect of either DSM18775 or MicroGARD onthe color or the taste of emulsion sausage when MA- or vacuum packed.However, the sensory panel noted a slightly acidic odor of thevacuum-packed emulsion sausage slices with added MicroGARD 730.

Regarding Deposited Microbial Organisms [EXPERT SOLUTION, Rule 13 bis.6(PCT)]

For all deposited microbial organisms mentioned in the present patentapplication the following applies.

As regards the respective Patent Offices of the respective designatedstates, the applicants request that a sample of the depositedmicroorganisms stated above only be made available to an expertnominated by the requester until the date on which the patent is grantedor the date on which the application has been refused or withdrawn or isdeemed to be withdrawn.

In particular it is requested, that regarding:

Europe

In respect to those designations in which a European Patent is sought asample or the deposited microorganism will be made available until thepublication of the mention of the grant of the European patent or untilthe date on which application has been refused or withdrawn or is deemedto be withdrawn, only by the issue of such a sample to an expertnominated by the person requesting the sample, and approved either i) bythe Applicant and/or ii) by the European Patent Office, whicheverapplies (Rule 32 EPC).

Canada

The applicant requests that, until either a Canadian patent has beenissued on the basis of an application or the application has beenrefused, or is abandoned and no longer subject to reinstatement, or iswithdrawn, the Commissioner of Patents only authorizes the furnishing ofa sample of the deposited biological material referred to in theapplication to an independent expert nominated by the Commissioner, theapplicant must, by a written statement, inform the International Bureauaccordingly before completion of technical preparations for publicationof the international application.

Australia

The applicant hereby gives notice that the furnishing of a sample of amicroorganism shall only be affected prior to the grant of a patent, orprior to the lapsing, refusal or withdrawal of the application, to aperson who is a skilled addressee without an interest in the invention.

Singapore

The applicant hereby requests that the furnishing of a sample of amicroorganism shall only be made available to an expert.

1.-7. (canceled)
 8. A process for preparing a composition capable ofinhibiting the growth of at least one food-borne pathogenic bacteriumsaid process comprising: (a) culturing cells of a strain ofLactobacillus curvatus deposited under accession number DSM 18775, whichupon culturing in a culture medium produces a bacteriocin which hasinhibitory activity against bacterial strains including Listeriamonocytogenes, to obtain a supernatant comprising the bacteriocin; and(c) separating the supernatant from the cultured cells to obtain thesupernatant, thus obtaining a supernatant composition comprising thebacteriocin.
 9. The process according to claim 8 which further comprisea drying step to obtain a dried culture eluate.
 10. The processaccording to claim 9 wherein the drying step is freeze drying or spraydrying.
 11. The process according to claim 8, wherein effective amountsof the growth inhibiting composition have a bacteriocidal effect on theat least one food-borne pathogenic bacterium.
 12. The process accordingto claim 8, wherein the at least one food-borne pathogenic bacterium isListeria monocytogenes.
 13. The composition resulting from the processof claim
 8. 14. A bacteriocin which has inhibitory activity againstbacterial strains including Listeria monocytogenes obtainable by aprocess that includes the process of claim
 8. 15.-17. (canceled)